Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
---|---|---|---|---|---|---|
SC 13D/A | 2024-03-13 | 5AM Partners VII, LLC | Skye Bioscience, Inc. | 10,098,912 | 33.9% | EDGAR |
SC 13G | 2024-02-08 | SPHERA FUNDS MANAGEMENT LTD. | Skye Bioscience, Inc. | 1,301,518 | 5.4% | EDGAR |
SC 13G | 2024-02-05 | Altium Capital Management LP | Skye Bioscience, Inc. | 1,301,518 | 5.4% | EDGAR |
SC 13D/A | 2024-01-31 | 5AM Partners VII, LLC | Skye Bioscience, Inc. | 9,648,913 | 37.3% | EDGAR |
SC 13D | 2023-08-28 | 5AM Partners VII, LLC | Skye Bioscience, Inc. | 1,110,709,567 | 31.7% | EDGAR |
SC 13G | 2023-08-28 | Versant Venture Capital III, L.P. | Skye Bioscience, Inc. | 629,022,108 | 19.6% | EDGAR |
SC 13D/A | 2023-03-20 | Emerald Health Sciences Inc. | Skye Bioscience, Inc. | 169,407,901 | 17.4% | EDGAR |
SC 13D/A | 2022-01-31 | Emerald Health Sciences Inc. | Skye Bioscience, Inc. | 124,280,934 | 23.4% | EDGAR |
SC 13G/A | 2022-01-05 | SABBY MANAGEMENT, LLC | Skye Bioscience, Inc. | 2,000,000 | 0.4% | EDGAR |
SC 13G/A | 2021-02-16 | ARMISTICE CAPITAL, LLC | Skye Bioscience, Inc. | 12,603,182 | 5.0% | EDGAR |
SC 13G/A | 2021-02-05 | BIGGER CAPITAL FUND L P | Skye Bioscience, Inc. | 1,000,000 | 1.1% | EDGAR |
SC 13G/A | 2021-01-07 | SABBY MANAGEMENT, LLC | Emerald Bioscience, Inc. | 14,480,000 | 5.8% | EDGAR |
SC 13D/A | 2020-08-17 | Emerald Health Sciences Inc. | Emerald Bioscience, Inc. | 124,049,826 | 49.2% | EDGAR |
SC 13G | 2020-08-10 | ARMISTICE CAPITAL, LLC | Emerald Bioscience, Inc. | 15,187,057 | 6.3% | EDGAR |
SC 13G | 2020-08-07 | BIGGER CAPITAL FUND L P | Emerald Bioscience, Inc. | 7,083,833 | 3.0% | EDGAR |
SC 13G | 2020-07-31 | SABBY MANAGEMENT, LLC | Emerald Bioscience, Inc. | 15,000,000 | 6.3% | EDGAR |
SC 13D/A | 2020-01-28 | Emerald Health Sciences Inc. | Emerald Bioscience, Inc. | 126,490,167 | 64.7% | EDGAR |
SC 13D/A | 2019-04-01 | Emerald Health Sciences Inc. | Emerald Bioscience, Inc. | 136,453,917 | 69.2% | EDGAR |
SC 13D/A | 2019-02-04 | Emerald Health Sciences Inc. | Nemus Bioscience, Inc. | 128,953,917 | 68.0% | EDGAR |
SC 13D/A | 2018-11-02 | Emerald Health Sciences Inc. | Nemus Bioscience, Inc. | 121,416,250 | 66.6% | EDGAR |